Oncology & Cancer

New drug for blood cancers now in five phase II clinical trials

Researchers at University of California, San Diego School of Medicine have established the safety and dosing of a new drug for treating blood cancers. The findings are published online July 27 in The Lancet Haematology.

HIV & AIDS

Small breakthroughs offer big hope of AIDS 'cure'

Small but significant breakthrough studies on people who have been able to overcome or control HIV were presented Thursday at a major world conference on ways to stem the three-decade-old disease.

Medical research

Why long-suffering hosts grow a thick skin

Occasionally, following a transplant procedure, the donor's immune cells recognize the recipient's tissues as foreign and trigger a multisystem disorder called graft-versus-host disease (GVHD). Occurring commonly after bone ...

Oncology & Cancer

Sensing 'junk' RNA after chemotherapy enhances blood regeneration

Chemotherapy is widely used to treat cancer patients. During the treatment, chemotherapeutic agents affect various biochemical processes to kill or reduce the growth of cancer cells, which divide uncontrollably in patients. ...

page 37 from 40